Internal Medicine, Endocrinology, Diabetes, & Metabolism · Feasterville Trevose, PA
NPI
1457354581
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4 Rose Ave, Suite A
Feasterville Trevose, PA, 19053
Phone (215) 953-6804
Groups this clinician bills Medicare through
Medicare paid, 2024
$127K
2,544 services
Medicare patients, 2024
481
Average age 73
Drug cost, 2024
$3.1M
8,232 prescriptions
Company payments, 2025
$5,973
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Arvind R Cavale was code 95251 (test - miscellaneous), 903 times for 206 patients. In total Arvind R Cavale billed 2,544 services in 19 codes, and Medicare paid $127K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-11-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95251 Test - Miscellaneous | Office | 903 | 206 | $26.54 | $24K |
| 99214 Office E&M - Established | Office | 540 | 308 | $95.53 | $52K |
| 99213 Office E&M - Established | Office | 537 | 346 | $64.89 | $35K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 444 | 299 | $12.24 | $5,433 |
| 99205 Office E&M - New | Office | 27 | 27 | $159.30 | $4,301 |
| 95250 Test - Miscellaneous | Office | 20 | 19 | $116.50 | $2,330 |
| 99442 Telephone Services | Office | 13 | 12 | $62.29 | $810 |
| 99215 Office E&M - Established | Office | 12 | 11 | $129.20 | $1,550 |
| 95249 Test - Miscellaneous | Office | 11 | 11 | $53.60 | $590 |
By year: 2022 $124K for 1,959 services; 2023 $131K for 2,280 services; 2024 $127K for 2,544 services.
Medicare prescription drug claims, 2024
In 2024, the drug Arvind R Cavale prescribed most often to Medicare patients was Levothyroxine Sodium, with 968 prescriptions and refills. In total Arvind R Cavale wrote 8,232 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 968 | 2,758 | 242 | $15K |
| Repaglinide Generic | 681 | 1,710 | 159 | $31K |
| Mounjaro Tirzepatide | 379 | 434 | 57 | $446K |
| Rosuvastatin Calcium Generic | 375 | 1,057 | 117 | $6,706 |
| Synthroid Levothyroxine Sodium | 322 | 807 | 71 | $23K |
| Metformin Hcl Generic | 308 | 853 | 90 | $3,473 |
| Trijardy Xr Empaglifloz/Linaglip/Metformin | 250 | 463 | 46 | $263K |
| Trulicity Dulaglutide | 248 | 341 | 44 | $319K |
| Novolog Flexpen Insulin Aspart | 197 | 478 | 77 | $60K |
| Jardiance Empagliflozin | 164 | 344 | 43 | $197K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 161 | 346 | 62 | $18K |
| Alendronate Sodium Generic | 147 | 387 | 39 | $1,631 |
| Fenofibrate Fenofibrate,micronized | 144 | 425 | 48 | $4,562 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 139 | 426 | 53 | $19K |
| Atorvastatin Calcium Generic | 134 | 371 | 41 | $1,341 |
Brand drugs: 3,619 claims; generic drugs: 4,032 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Arvind R Cavale $5,973 ($5,973 in general payments such as food, travel and fees) from 6 companies. The largest payer was Ascendis Pharma Endocrinology Inc with $5,928.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.